In the bio-tech market, Nasdaq Inc. has been quite active with notable developments and considerable market movement. Trading has resumed in BAIYU Holdings, Inc., signaling a positive recovery. PureStream, Nasdaq's advanced trade tech has expanded its presence in Europe, indicating the company’s global expansion strategy. Additionally, end-of-month open short interest positions have been released as of settlement date September 30, 2024. Noteworthy changes include Tobam reducing its holdings, and the Czech National Bank acquiring more stock. Analysts toward Nasdaq's performance include TD Cowen maintaining a hold rating. Also, there are predictions for a Nasdaq rally of around 13%, further supported by Royal Bank of Canada and RBC Capital's Outperform ratings.
Moving on, Nasdaq is seeing a significant increase in IPO activity, with 66 IPOs welcomed in the first half of 2024. The company has acquired Adenza, resulting in the stock rallying by 42.5%. Its Q4 2023 earnings report is also expected. In Latin America, the company has also expanded its FinTech Presence. The top shareholder Thoma Bravo is planning to sell shares worth $2.8 billion as part of a secondary offering of Nasdaq Common Stock. Lastly, Nasdaq’s revenue has seen an increase due to high demand for its fintech products.
Nasdaq NDAQ News Analytics from Sat, 27 Jan 2024 08:00:00 GMT to Fri, 11 Oct 2024 08:55:17 GMT - Rating 7 - Innovation 5 - Information 8 - Rumor 4
